345 — Vitasoy International Holdings Balance Sheet
0.000.00%
- HK$6.95bn
- HK$6.31bn
- HK$6.27bn
Annual balance sheet for Vitasoy International Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 971 | 622 | 555 | 794 | 1,268 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,274 | 1,161 | 1,001 | 891 | 824 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,970 | 2,556 | 2,196 | 2,247 | 2,626 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,142 | 3,965 | 3,389 | 3,102 | 2,775 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,276 | 6,807 | 5,850 | 5,637 | 5,649 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,084 | 3,032 | 2,472 | 2,225 | 2,142 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,660 | 3,549 | 2,865 | 2,632 | 2,566 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 3,616 | 3,258 | 2,985 | 3,005 | 3,083 |
| Total Liabilities & Shareholders' Equity | 7,276 | 6,807 | 5,850 | 5,637 | 5,649 |
| Total Common Shares Outstanding |